Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | UGT2B7 | P16662 | 7/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1105231 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL3112008 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL31139943 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL8611875 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL3112011 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL19958385 | 0.87 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL27017541 | 0.87 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL385019 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL10101191 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL9880760 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3994117-B1 | HYDROGENATION OF ESTERS TO ALCOHOLS IN THE PRESENCE OF A RU-PNN COMPLEX | BASF SE (DE) | 2024-07-03 | — | — | EP | disclosed |
| US-11708316-B2 | Hydrogenation of esters to alcohols in the presence of a Ru-PNN complex | BASF SE (DE) | 2023-07-25 | — | — | US | disclosed |
| US-11708316-B2 | Hydrogenation of esters to alcohols in the presence of a Ru-PNN complex | BASF SE (DE) | 2023-07-25 | — | — | US | disclosed |
| US-20230021613-A1 | SQUALENE HOPENE CYCLASE (SHC) VARIANTS | GIVAUDAN SA (CH) | 2023-01-26 | — | — | US | disclosed |
| US-20220380279-A1 | HYDROGENATION OF ESTERS TO ALCOHOLS IN THE PRESENCE OF A RU-PNN COMPLEX | BASF SE (DE) | 2022-12-01 | — | — | US | disclosed |
| US-11021722-B2 | Enzymes and applications thereof | GIVAUDAN S.A. (CH) | 2021-06-01 | — | — | US | disclosed |
| WO-2021001240-A1 | HYDROGENATION OF ESTERS TO ALCOHOLS IN THE PRESENCE OF A RU-PNN COMPLEX | BASF SE (DE) | 2021-01-07 | — | — | WO | disclosed |
| EP-2471939-B1 | Method for producing 1-(2-hydroxyethyl) 2,5,5,8a-tetramethyldecahydronaphthalene-2-ol by microbial fermentation | KAO CORP (JP) | 2020-11-04 | — | — | EP | disclosed |
| US-20200040369-A1 | ENZYMES AND APPLICATIONS THEREOF | GIVAUDAN SA (CH) | 2020-02-06 | — | — | US | disclosed |
| US-10472655-B2 | Enzymes and applications thereof | GIVAUDAN S.A. (CH) | 2019-11-12 | — | — | US | disclosed |
| US-20120135484-A1 | METHOD FOR PRODUCING MICROBIAL FERMENTATION PRODUCT | KAO CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20120135484-A1 | METHOD FOR PRODUCING MICROBIAL FERMENTATION PRODUCT | KAO CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20100274030-A1 | CYCLIC ETHERS | GIVAUDAN S.A. (CH) | 2010-10-28 | — | — | US | disclosed |
| US-20100248316-A1 | Process for the Production of Ambrafuran | CSIR (ZA) | 2010-09-30 | — | — | US | disclosed |
| US-20100233766-A1 | Novel Microorganism and Method for Producing Dodecahydro-3a,6,6,9a-Tetramethylnaphtho[2,1-b]Furan Intermediate Using the Novel Microorganism | KAO CORPORATION (JP) | 2010-09-16 | — | — | US | disclosed |
| US-20100028964-A1 | METHOD FOR PRODUCTION OF MICROBIAL FERMENTATION PRODUCT | KAO CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100028964-A1 | METHOD FOR PRODUCTION OF MICROBIAL FERMENTATION PRODUCT | KAO CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| WO-2009010791-A2 | CYCLIC ETHERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 2009-01-22 | — | — | WO | disclosed |
| US-7294492-B2 | Process for the manufacture of spiroketals | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-11-13 | — | — | US | disclosed |
| US-7294492-B2 | Process for the manufacture of spiroketals | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11021722-B2 | Enzymes and applications thereof | HAO1, HLCS, HACL2 | ALDH1A1 1307/4885CYP3A4 1666/4885CYP2C9 992/4885 |
| US-20200040369-A1 | ENZYMES AND APPLICATIONS THEREOF | HAO1, HLCS, HACL2 | ALDH1A1 1307/4885CYP3A4 1666/4885CYP2C9 992/4885 |
| US-20100274030-A1 | CYCLIC ETHERS | TET3, TET1, DOHH | ALDH1A1 1597/4885CYP3A4 281/4885CYP2C9 306/4885 |
| US-20220380279-A1 | HYDROGENATION OF ESTERS TO ALCOHOLS IN THE PRESENCE OF A RU-PNN COMPLEX | ADH1A, PNN, ADH1C | ALDH1A1 103/4885CYP3A4 125/4885CYP2C9 674/4885 |
| US-10472655-B2 | Enzymes and applications thereof | HAO1, HLCS, HACL2 | ALDH1A1 1307/4885CYP3A4 1666/4885CYP2C9 992/4885 |
| US-11708316-B2 | Hydrogenation of esters to alcohols in the presence of a Ru-PNN complex | ADH1A, PNN, ADH1C | ALDH1A1 103/4885CYP3A4 125/4885CYP2C9 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.